Latest Breaking News On - Herapy gmda il0011552663 - Page 1 : comparemela.com

By Josh Beckerman Gamida Cell Ltd. shares rose 34% to $1.08 Monday after the U.S. Food and Drug Administration approved the Boston-based biotechnology company s Omisirge cell therapy for. | April 17, 2023

United statesJosh beckermanGamida cell ltdDrug administrationDow jonesGamida cell ltd stock exchangePress releaseHerapy gmda il0011552663